[Webinar] Value Assessment in the Age of COVID-19: Meeting the Challenges
An important discussion is developing around Value Assessment (VA) and Health Technology Assessment (HTA) as COVID-19 intensifies challenges to effectively [...]
Teva Pharmaceuticals Stock Plunges 15.4%
Teva Pharmaceutical stands accused of defrauding Medicare using a kickback scheme to boost sales of Copaxone, prompting the US government [...]
[Video Chat] A Pandemic Means Society Needs Information Fast. Can Researchers Provide It?
Don't miss Stat's upcoming video chat on Thursday, Sept. 17 at 1 p.m. ET / 10 a.m. PT: Getting real [...]
[PODCAST] Open Access: Opportunities and Challenges
As the principles of open science become more widely adopted, open access publishing is an increasingly debated topic. Join International [...]
Payer Contact in a “Contactless” World: Achieving Early Engagement
The COVID-19 pandemic has prompted life sciences organizations to quickly pivot their payer strategic approach and tactical implementation. Engaging payers [...]
How is Patient-Centered Outcomes Research Institute (PCORI) Contributing to The Fight Against COVID-19?
In response to the COVID-19 pandemic, the Patient-Centered Outcomes Research Institute (PCORI) has approved over $20 million in funding for [...]
Highmark and UCB Partner on Outcomes-based Contract for CIMZIA
Highmark has entered an outcomes-based agreement with UCB, Inc. for CIMZIA® (certolizumab pegol), UCB’s tumor necrosis factor blocker prescribed for [...]
Study Finds That Less Than 20% of Medicare Spending is Value-based
Boston-based health insurance company Coverys found that less than 20% of Medicare spending is value-based. In order to meet future [...]
How Are the U.S. Postal Service’s Woes Affecting Prescriptions?
There is increasing concern among physicians and policymakers that uncertainty concerning the fate of the U.S. Postal Service could delay [...]
How Can Chief Outcomes Officers Transform the C-Suite?
Improving outcomes, lowering costs, and increasing satisfaction are universal goals that few health care organizations or consumers feel they have [...]
Pharma14 adds South Korea to Global Medicine and Pricing Database
The pharmaceutical market in South Korea is undergoing rapid expansion and expected to reach more than US$ 21 billion by [...]
The Professional Society for Health Economics and Outcomes Research (ISPOR) Now Offers Renowned Short Course Program Virtually
ISPOR’s is offering the following virtual courses through its renowned short course program: September [...]
Course offering: Introduction to Medical Affairs in Medicines Development
Don’t miss out on this exciting new course covering the fundamentals of Medicines Development and how Medical Affairs functions bring [...]
How Does Consolidation Drive Prices?
Why do Americans spend so much on healthcare? According to a recent literature review, part of the reason may be [...]
Kamala Harris Is No Friend to Pharma
Vice presidential nominee Kamala Harris is not exactly the centrist the media are making her out to be—especially when it [...]
Towards a Better Understanding of Outcome-Based Contracts
Outcome-based contracting is an operational model that requires an ironclad relationship between customer and provider that provides the trust necessary [...]
Although COVID-19 has Dampened Pharma Sales in 2020, Outlook to 2026 is still Optimistic
According to the EvaluatePharma World Preview 2020, Outlook to 2026 report, COVID-19 has reduced biopharma sales forecasts by $7.85bn with [...]
The Most Expensive Drugs in the U.S. According to GoodRx
GoodRx has released its latest list of the most expensive drugs in America, with orphan drugs and therapies for rare [...]
Proposed change to CMS Rules Aim Will Expand Access to High-cost Therapies for Medicaid Recipients
The Medicaid Best Price rule requires drug manufacturers to give Medicaid the best price on all purchases. However, the rule [...]
How COVID-19 Provides Opportunities to Implement Value-Based Care Practices
COVID-19 has drastically changed the healthcare landscape for payers and providers as telehealth services are increasingly utilized. Experts discussed how [...]
Webinar Recap: It’s Time to Talk About COVID-19 Prices
Join National Pharmaceutical Council Chief Science Officer Robert Dubois, Memorial Sloan Kettering Cancer Center's Peter Bach, Institute for Clinical and [...]
Value-based Models Achieve Better Patient Outcomes in Primary Care Practices
A new study from United Health Group shows that primary care physicians (PCPs) perform better on key quality metrics when [...]
How Effective is Precision Medicine in the Fight Against Lung Cancer?
Precision medicine, an approach that relies on drugs that target specific genes, has produced specular results by saving many individual [...]
Post-Pandemic Paradigm Shifts and New Dimensions of Value, a DIA DIRECT webinar
The current pandemic has forced us to recognize the weaknesses of our current social, economic, and healthcare systems and rethink [...]
BHE Rebrands Itself as Panalgo In Effort To Empower Pharma, Payers and Providers With Trusted Analytics.
BHE has rebranded itself as Panalgo to better expand access to reliable health analytics using their Instant Health Data (IHD) [...]